Fastest Growing Stocks
ISRG is part of our fastest growing stocks screen, indicating it has high EPS and sales growth.
INTUITIVE SURGICAL INC (ISRG) Stock Price & Overview
NASDAQ:ISRG • US46120E6023
Current stock price
469.21 USD
+11.13 (+2.43%)
At close:
470.552 USD
+1.34 (+0.29%)
After Hours:
The current stock price of ISRG is 469.21 USD. Today ISRG is up by 2.43%. In the past month the price decreased by -2.23%. In the past year, price decreased by -2.8%.
ISRG Key Statistics
52-Week Range427.836 - 603.88
Current ISRG stock price positioned within its 52-week range.
1-Month Range447.775 - 489
Current ISRG stock price positioned within its 1-month range.
- Market Cap
- 166.649B
- P/E
- 52.54
- Fwd P/E
- 45.92
- EPS (TTM)
- 8.93
- Dividend Yield
- N/A
ISRG Stock Performance
Today
+2.43%
1 Week
+4.13%
1 Month
-2.23%
3 Months
-12.30%
Longer-term
6 Months +5.17%
1 Year -2.80%
2 Years +26.60%
3 Years +55.77%
5 Years +62.73%
10 Years +574.20%
ISRG Stock Chart
ISRG Stock Screens
ISRG currently appears in the following ChartMill screener lists.
ISRG Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ISRG. When comparing the yearly performance of all stocks, ISRG is a bad performer in the overall market: 80.58% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ISRG Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ISRG. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ISRG Earnings
On January 22, 2026 ISRG reported an EPS of 2.53 and a revenue of 2.87B. The company beat EPS expectations (9.85% surprise) and beat revenue expectations (2.22% surprise).
Next Earnings DateApr 21, 2026
Last Earnings DateJan 22, 2026
PeriodQ4 / 2025
EPS Reported$2.53
Revenue Reported2.866B
EPS Surprise 9.85%
Revenue Surprise 2.22%
ISRG Forecast & Estimates
41 analysts have analysed ISRG and the average price target is 615.86 USD. This implies a price increase of 31.25% is expected in the next year compared to the current price of 469.21.
For the next year, analysts expect an EPS growth of 14.43% and a revenue growth 15.83% for ISRG
Analysts
Analysts79.02
Price Target615.86 (31.25%)
EPS Next Y14.43%
Revenue Next Year15.83%
ISRG Groups
Sector & Classification
ISRG Financial Highlights
Over the last trailing twelve months ISRG reported a non-GAAP Earnings per Share(EPS) of 8.93. The EPS increased by 21.83% compared to the year before.
Income Statements
Revenue(TTM)10.06B
Net Income(TTM)2.86B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.38% | ||
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%14.48%
Sales Q2Q%18.76%
EPS 1Y (TTM)21.83%
Revenue 1Y (TTM)20.51%
ISRG Ownership
Ownership
Inst Owners88.75%
Shares355.17M
Float352.81M
Ins Owners0.46%
Short Float %1.91%
Short Ratio3.67
ISRG Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 15.41 | 165.895B | ||
| SYK | STRYKER CORP | 22.7 | 129.593B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.42 | 94.254B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.88 | 45.576B | ||
| IDXX | IDEXX LABORATORIES INC | 39.79 | 45.265B | ||
| BDX | BECTON DICKINSON AND CO | 11.62 | 44.083B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 33.4B | ||
| RMD | RESMED INC | 18.58 | 32.737B | ||
| DXCM | DEXCOM INC | 25.16 | 23.565B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.18 | 18.347B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.42 | 14.184B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ISRG
Company Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company Info
IPO: 2000-06-13
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA 94086 US
CEO: Gary S. Guthart
Employees: 17021
Phone: 13026587581
INTUITIVE SURGICAL INC / ISRG FAQ
Can you describe the business of INTUITIVE SURGICAL INC?
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
What is the stock price of INTUITIVE SURGICAL INC today?
The current stock price of ISRG is 469.21 USD. The price increased by 2.43% in the last trading session.
What is the dividend status of INTUITIVE SURGICAL INC?
ISRG does not pay a dividend.
How is the ChartMill rating for INTUITIVE SURGICAL INC?
ISRG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
How is the valuation of INTUITIVE SURGICAL INC (ISRG) based on its PE ratio?
The PE ratio for INTUITIVE SURGICAL INC (ISRG) is 52.54. This is based on the reported non-GAAP earnings per share of 8.93 and the current share price of 469.21 USD.
Would investing in INTUITIVE SURGICAL INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ISRG.
What is the expected growth for ISRG stock?
The Revenue of INTUITIVE SURGICAL INC (ISRG) is expected to grow by 15.83% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.